Wealthfront Corp (WLTH) officer details RSU vesting and IPO sale

Rhea-AI Filing Summary

Wealthfront Corp executive Lauren Lin, the company's CLO, CCO and Secretary, reported multiple equity transactions. On 12/11/2025, several restricted stock unit awards were settled into common stock at an exercise price of $0, increasing her direct holdings before taxes.

On the same date, 129,493 shares of common stock were withheld at $14 per share to satisfy tax withholding obligations, and 30,229 shares were sold at $14 per share as part of the company's secondary offering conducted in conjunction with its IPO. After these transactions, she directly owned 95,279 shares of common stock.

The filing also reports a new grant on 09/26/2025 of 205,550 restricted stock units. These units became performance-eligible in connection with the IPO and are scheduled to vest in 16 equal quarterly installments on the fifteenth day of March, June, September and December, beginning December 15, 2025, subject to her continued service.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lin Lauren

(Last) (First) (Middle)

C/O WEALTHFRONT CORPORATION

261 HAMILTON AVENUE

(Street)

PALO ALTO CA 94301

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
WEALTHFRONT CORP [ WLTH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CLO, CCO and Secretary

3. Date of Earliest Transaction (Month/Day/Year)
09/26/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/11/2025		M		5,237	A	$0	5,237	D
Common Stock	12/11/2025		M		17,014	A	$0	22,251	D
Common Stock	12/11/2025		M		1,500	A	$0	23,751	D
Common Stock	12/11/2025		M		137,500	A	$0	161,251	D
Common Stock	12/11/2025		M		75,000	A	$0	236,251	D
Common Stock	12/11/2025		M		18,750	A	$0	255,001	D
Common Stock	12/11/2025		F(1)		129,493	D	$14	125,508	D
Common Stock	12/11/2025		S(2)		30,229	D	$14	95,279	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(3)	09/26/2025(4)(5)		A		205,550		(6)	(7)	Common Stock	205,550	$0	205,550	D
Restricted Stock Units	(3)	12/11/2025		M			5,237	(8)	(7)	Common Stock	5,237	$0	0	D
Restricted Stock Units	(3)	12/11/2025		M			17,014	(9)	(7)	Common Stock	17,014	$0	2,431	D
Restricted Stock Units	(3)	12/11/2025		M			1,500	(10)	(7)	Common Stock	1,500	$0	0	D
Restricted Stock Units	(3)	12/11/2025		M			137,500	(11)	(7)	Common Stock	137,500	$0	62,500	D
Restricted Stock Units	(3)	12/11/2025		M			75,000	(12)	(7)	Common Stock	75,000	$0	75,000	D
Restricted Stock Units	(3)	12/11/2025		M			18,750	(13)	(7)	Common Stock	18,750	$0	56,250	D

Explanation of Responses:

1. The transaction represents the number of shares of Common Stock withheld by the Issuer to satisfy tax withholding liabilities in connection with the net settlement of restricted stock units.

2. The reported sale transaction represents the reporting person's participation in the Issuer's secondary offering, which occurred in conjunction with its initial public offering ("IPO").

3. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock upon settlement.

4. The transaction occurred prior to the Issuer's registration of a class of equity securities under Section 12 of the Securities Exchange Act of 1934, as amended, in connection with the IPO, and the transaction is reported herein pursuant to Rule 16a-2(a).

5. This restricted stock unit award represents an equity security previously reported on the reporting person's Form 3, which was acquired through an exempt transaction with the Issuer.

6. The award was granted subject to a performance-based vesting condition which was satisfied in connection with the IPO, as well as a service-based vesting schedule. The award shall vest as to 1/16 of the total award quarterly on the fifteenth calendar day of December, March, June, and September, subject to the reporting person's continued service to the Issuer on each vesting date, with the first tranche vesting on December 15, 2025.

7. These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date.

8. The award was granted subject to a performance-based vesting condition which was satisfied in connection with the IPO, as well as a service-based vesting schedule. The award vested as to 1/8 of the total award quarterly on the fifteenth calendar day of March, June, September, and December, subject to the reporting person's continued service to the Issuer on each vesting date, with the first tranche time-vested on March 15, 2023. The award was fully time-vested as of December 15, 2024, and the entire award was settled for shares of the Issuer's Common Stock in connection with the IPO.

9. The award was granted subject to a performance-based vesting condition which was satisfied in connection with the IPO, as well as a service-based vesting schedule. The award vested or vests as to 1/16 of the total award quarterly on the fifteenth calendar day of June, September, December, and March, subject to the reporting person's continued service to the Issuer on each vesting date, with the first tranche time-vested on June 15, 2022. Time-vested portions of the award were settled for shares of the Issuer's Common Stock in connection with the IPO.

10. The award was granted subject to a performance-based vesting condition which was satisfied in connection with the IPO and a service-based vesting requirement which was deemed satisfied as of the grant date, November 22, 2022. The entire award was settled for shares of the Issuer's Common Stock in connection with the IPO.

11. The award was granted subject to a performance-based vesting condition which was satisfied in connection with the IPO, as well as a service-based vesting schedule. The award vested or vests as to 1/16 of the total award quarterly on the fifteenth calendar day of March, June, September, and December, subject to the reporting person's continued service to the Issuer on each vesting date, with the first tranche time-vested on March 15, 2023. Time-vested portions of the award were settled for shares of the Issuer's Common Stock in connection with the IPO.

12. The award was granted subject to a performance-based vesting condition which was satisfied in connection with the IPO, as well as a service-based vesting schedule. The award vested or vests as to 1/16 of the total award quarterly on the fifteenth calendar day of December, March, June, and September, subject to the reporting person's continued service to the Issuer on each vesting date, with the first tranche time-vested on December 15, 2023. Time-vested portions of the award were settled for shares of the Issuer's Common Stock in connection with the IPO.

13. The award was granted subject to a performance-based vesting condition which was satisfied in connection with the IPO, as well as a service-based vesting schedule. The award vested or vests as to 1/16 of the total award quarterly on the fifteenth calendar day of December, March, June, and September, subject to the reporting person's continued service to the Issuer on each vesting date, with the first tranche time-vested on December 15, 2024. Time-vested portions of the award were settled for shares of the Issuer's Common Stock in connection with the IPO.

	/s/ Lauren Lin	12/15/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider stock transactions did Wealthfront Corp (WLTH) disclose for Lauren Lin?

The report shows that on 12/11/2025, CLO, CCO and Secretary Lauren Lin had multiple restricted stock unit awards settle into common stock at an exercise price of $0, followed by tax-related share withholding and an open-market sale tied to the company’s IPO-related secondary offering.

How many Wealthfront shares did Lauren Lin sell and at what price?

Lauren Lin sold 30,229 shares of Wealthfront common stock on 12/11/2025 at a price of $14 per share. The filing explains that this sale reflects her participation in the company’s secondary offering conducted in conjunction with its IPO.

How many Wealthfront shares were withheld for taxes from Lauren Lin’s awards?

The filing states that 129,493 shares of Wealthfront common stock were withheld on 12/11/2025 at $14 per share. These shares were retained by the issuer to satisfy tax withholding liabilities arising from the net settlement of restricted stock units.

What new restricted stock unit grant did Lauren Lin receive from Wealthfront?

On 09/26/2025, Lauren Lin received a grant of 205,550 restricted stock units. Each unit represents a contingent right to receive one share of Wealthfront common stock, with a performance condition satisfied in connection with the IPO and a service-based schedule under which 1/16 of the award vests quarterly beginning December 15, 2025.

How many Wealthfront shares does Lauren Lin own after the reported transactions?

After the reported transactions on 12/11/2025, Lauren Lin directly owned 95,279 shares of Wealthfront common stock. She also holds several outstanding restricted stock unit awards that either vest or are cancelled on future vesting dates, according to their individual schedules.